BE896700A - Medicaments contenant un derive du psoralene. - Google Patents

Medicaments contenant un derive du psoralene.

Info

Publication number
BE896700A
BE896700A BE0/210731A BE896700A BE896700A BE 896700 A BE896700 A BE 896700A BE 0/210731 A BE0/210731 A BE 0/210731A BE 896700 A BE896700 A BE 896700A BE 896700 A BE896700 A BE 896700A
Authority
BE
Belgium
Prior art keywords
products containing
medicinal products
psoralene derivative
psoralene
derivative
Prior art date
Application number
BE0/210731A
Other languages
English (en)
Original Assignee
Goupil Jean Jacques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR8206262A priority Critical patent/FR2524801B1/fr
Application filed by Goupil Jean Jacques filed Critical Goupil Jean Jacques
Priority to BE0/210731A priority patent/BE896700A/fr
Priority to CH2751/83A priority patent/CH656801A5/fr
Priority to IT21216/83A priority patent/IT1169415B/it
Priority to AU14905/83A priority patent/AU559029B2/en
Priority to CA000428960A priority patent/CA1205386A/fr
Priority to JP58097768A priority patent/JPH0653664B2/ja
Priority to GB08315070A priority patent/GB2140686B/en
Publication of BE896700A publication Critical patent/BE896700A/fr
Priority to US07/395,283 priority patent/US4970230A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE0/210731A 1982-04-09 1983-05-09 Medicaments contenant un derive du psoralene. BE896700A (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR8206262A FR2524801B1 (fr) 1982-04-09 1982-04-09 Medicaments contenant un derive du psoralene
BE0/210731A BE896700A (fr) 1982-04-09 1983-05-09 Medicaments contenant un derive du psoralene.
CH2751/83A CH656801A5 (fr) 1982-04-09 1983-05-19 Medicaments contenant un derive du psoralene.
IT21216/83A IT1169415B (it) 1983-05-09 1983-05-20 Prodotti medicinali contenenti un derivato del psoralene
AU14905/83A AU559029B2 (en) 1982-04-09 1983-05-24 Drugs containing a psoralene derivative
CA000428960A CA1205386A (fr) 1982-04-09 1983-05-26 Medicaments contenant un derive psoralene
JP58097768A JPH0653664B2 (ja) 1982-04-09 1983-06-01 プソラレン誘導体含有薬剤
GB08315070A GB2140686B (en) 1982-04-09 1983-06-01 Drugs containing a psoralene derivative
US07/395,283 US4970230A (en) 1983-05-09 1989-08-09 Drugs containing a psoralene derivative

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8206262A FR2524801B1 (fr) 1982-04-09 1982-04-09 Medicaments contenant un derive du psoralene
BE0/210731A BE896700A (fr) 1982-04-09 1983-05-09 Medicaments contenant un derive du psoralene.

Publications (1)

Publication Number Publication Date
BE896700A true BE896700A (fr) 1983-09-01

Family

ID=36782343

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/210731A BE896700A (fr) 1982-04-09 1983-05-09 Medicaments contenant un derive du psoralene.

Country Status (7)

Country Link
JP (1) JPH0653664B2 (fr)
AU (1) AU559029B2 (fr)
BE (1) BE896700A (fr)
CA (1) CA1205386A (fr)
CH (1) CH656801A5 (fr)
FR (1) FR2524801B1 (fr)
GB (1) GB2140686B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992017208A1 (fr) * 1991-03-26 1992-10-15 Bioglan Laboratories Ltd. Composition emolliente

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2695036B1 (fr) * 1992-09-03 1994-10-28 Goupil Jean Jacques Huile contenant du 5-méthoxypsoralène à une concentration de 60 à 100 PPM et son utilisation pour le traitement du psoriasis.
US5556612A (en) * 1994-03-15 1996-09-17 The General Hospital Corporation Methods for phototherapeutic treatment of proliferative skin diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2406444A1 (fr) * 1977-10-21 1979-05-18 Goupil Jean Jacques Nouveau medicament contenant un derive du psoralene
LU80347A1 (fr) * 1977-10-21 1979-03-16 Goupil J 5-methoxy-psoralene comme nouveau medicament et procede de synthese

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992017208A1 (fr) * 1991-03-26 1992-10-15 Bioglan Laboratories Ltd. Composition emolliente

Also Published As

Publication number Publication date
FR2524801B1 (fr) 1985-08-30
CH656801A5 (fr) 1986-07-31
JPH0653664B2 (ja) 1994-07-20
GB8315070D0 (en) 1983-07-06
FR2524801A1 (fr) 1983-10-14
GB2140686B (en) 1986-09-17
JPS59222413A (ja) 1984-12-14
AU1490583A (en) 1984-11-29
GB2140686A (en) 1984-12-05
AU559029B2 (en) 1987-02-19
CA1205386A (fr) 1986-06-03

Similar Documents

Publication Publication Date Title
MC1418A1 (fr) 2,4-diamino-pyrimidines,leur preparation et medicaments contenant ces substances
ES514214A0 (es) Un preparado farmaceutico.
FR2555049B1 (fr) Medicaments a base de carboxymethoxy-7 furo-(3,4-c)-pyridine
FR2532848B1 (fr) Composition pharmaceutique contenant un derive polyprenylique
ES277103Y (es) Envase bolsa para productos medicinales.
DE3279806D1 (de) Corpuscules containing medicaments
FR2524314B1 (fr) Medicament a action salidiuretique, contenant des dihydropyridines
ZA81706B (en) Device for the administration of medicaments
IT8148992A0 (it) Confezione per sostanze medicamentose o medicinali a prova di bambino
BE877511A (fr) Medicaments du groupe des spirocetalines
GB2067900B (en) Medicinal tablets
BE896700A (fr) Medicaments contenant un derive du psoralene.
IT8321216A0 (it) Prodotti medicinali contenenti un derivato del psoralene.
ES529819A0 (es) Medicamento que contiene muzolimina
BE894729A (fr) Derives du phosphoramide, procede pour leur preparation et medicaments en contenant
AU84327S (en) a pharmaceutical dosage unit
FR2516793B1 (fr) Nouveaux medicaments immunomodulateurs contenant un derive de trithiazolepentamethylidene-cyanine
JPS5722755A (en) Partially packing machine for medicine
FI830399A0 (fi) Mjoeldryge-alkaloider, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska produkter
DE3167536D1 (en) 3-chloroquinoline derivatives, processes for their preparation and medicaments containing them
FI822980A0 (fi) Furanokromonderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska produkter
BE887468A (fr) Compositions pharmaceutiques contenant un derive de naphtyridine
BE896838A (nl) Polyfluoralkanolen bevattend geneesmiddel.
RO86393A2 (fr) Medicament a action vasculaire-trombocitaire
RO83817A2 (fr) Produit medicamenteux a action sedative-hypnogene

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: GOUPIL JEAN-JACQUES

Effective date: 19840509

RE Patent lapsed

Owner name: GOUPIL JEAN-JACQUES

Effective date: 19980531